Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

Bone Marrow Transplant. 2023 Jul;58(7):823-825. doi: 10.1038/s41409-023-01977-7. Epub 2023 Apr 3.

Authors

Omer Jamy¹, Kendall Diebold², Kenneth Davis³, Kimo Bachiashvili², Sravanti Rangaraju², Pankit Vachhani², Kelly N Godby², Donna Salzman², Ravi Bhatia²

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. omerjamy@uabmc.edu.
² Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
³ School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 37012416
DOI: 10.1038/s41409-023-01977-7

No abstract available

Publication types

Letter

MeSH terms

Humans
Karyotype
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy
Mutation
Prognosis
Tumor Suppressor Protein p53 / genetics

Substances

Tumor Suppressor Protein p53
TP53 protein, human